PL370361A1 - Alkyl urea retinoid agonists i - Google Patents
Alkyl urea retinoid agonists iInfo
- Publication number
- PL370361A1 PL370361A1 PL02370361A PL37036102A PL370361A1 PL 370361 A1 PL370361 A1 PL 370361A1 PL 02370361 A PL02370361 A PL 02370361A PL 37036102 A PL37036102 A PL 37036102A PL 370361 A1 PL370361 A1 PL 370361A1
- Authority
- PL
- Poland
- Prior art keywords
- cancer
- alkyl urea
- emphysema
- retinoid agonists
- dermatological disorders
- Prior art date
Links
- -1 Alkyl urea retinoid Chemical class 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 239000004202 carbamide Substances 0.000 title 1
- 206010014561 Emphysema Diseases 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32296301P | 2001-09-18 | 2001-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370361A1 true PL370361A1 (en) | 2005-05-16 |
Family
ID=33130243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02370361A PL370361A1 (en) | 2001-09-18 | 2002-09-11 | Alkyl urea retinoid agonists i |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6844466B2 (enExample) |
| EP (1) | EP1430024A1 (enExample) |
| JP (1) | JP4421293B2 (enExample) |
| KR (1) | KR100896550B1 (enExample) |
| CN (1) | CN1283621C (enExample) |
| AR (1) | AR036533A1 (enExample) |
| AU (1) | AU2002329276B2 (enExample) |
| BR (1) | BR0212583A (enExample) |
| CA (1) | CA2460693C (enExample) |
| MX (1) | MXPA04002590A (enExample) |
| PL (1) | PL370361A1 (enExample) |
| RU (1) | RU2299877C2 (enExample) |
| WO (1) | WO2003024921A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1636160A4 (en) * | 2003-06-23 | 2006-09-27 | Auspex Pharmaceuticals | NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER, METABOLISM AND SKIN DISEASES |
| WO2005108338A1 (en) * | 2004-05-03 | 2005-11-17 | Auspex Pharmaceuticals | Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| AU2006229904A1 (en) * | 2005-03-30 | 2006-10-05 | Merck Sharp & Dohme Corp. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| TW200821284A (en) * | 2006-10-03 | 2008-05-16 | Merck & Co Inc | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| DK3721880T3 (da) | 2010-09-01 | 2022-05-09 | Univ Jefferson | Sammensætning og fremgangsmåde til muskelreparation og regenerering |
| SG10201704687YA (en) | 2012-11-08 | 2017-07-28 | Univ Yamaguchi | Therapeutic agent for keratoconjunctive disorders |
| KR101426197B1 (ko) * | 2013-02-20 | 2014-08-01 | 여윤영 | 주먹밥틀 |
| CN105377258B (zh) | 2013-05-22 | 2020-08-28 | 国立大学法人山口大学 | 视网膜脉络膜病症的抑制剂 |
| CN105294567B (zh) * | 2015-10-29 | 2018-10-09 | 湖北新烯王生物科技有限公司 | 取代的3-氟苯基甲醇类化合物、药物组合物及用途 |
| MX390115B (es) | 2016-06-08 | 2025-03-20 | Clementia Pharmaceuticals Inc | Metodos para tratar la osificacion heterotopica. |
| AU2017359673B2 (en) | 2016-11-16 | 2021-10-21 | Clementia Pharmaceuticals Inc. | Methods for treating multiple osteochondroma (MO) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU87821A1 (fr) | 1990-10-12 | 1992-05-25 | Cird Galderma | Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique |
| EP0983991B1 (en) * | 1992-04-22 | 2003-12-17 | Ligand Pharmaceuticals, Inc. | Compounds having selectivity for retinoid x receptors |
| US6093742A (en) | 1997-06-27 | 2000-07-25 | Vertex Pharmaceuticals, Inc. | Inhibitors of p38 |
| JO2178B1 (en) | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
-
2002
- 2002-09-11 EP EP02764881A patent/EP1430024A1/en not_active Withdrawn
- 2002-09-11 JP JP2003528769A patent/JP4421293B2/ja not_active Expired - Fee Related
- 2002-09-11 WO PCT/EP2002/010179 patent/WO2003024921A1/en not_active Ceased
- 2002-09-11 RU RU2004111787/04A patent/RU2299877C2/ru not_active IP Right Cessation
- 2002-09-11 AU AU2002329276A patent/AU2002329276B2/en not_active Ceased
- 2002-09-11 CN CNB028181522A patent/CN1283621C/zh not_active Expired - Fee Related
- 2002-09-11 PL PL02370361A patent/PL370361A1/xx not_active IP Right Cessation
- 2002-09-11 MX MXPA04002590A patent/MXPA04002590A/es active IP Right Grant
- 2002-09-11 CA CA2460693A patent/CA2460693C/en not_active Expired - Fee Related
- 2002-09-11 KR KR1020047003931A patent/KR100896550B1/ko not_active Expired - Fee Related
- 2002-09-11 BR BR0212583-8A patent/BR0212583A/pt not_active Application Discontinuation
- 2002-09-16 AR ARP020103490A patent/AR036533A1/es unknown
- 2002-09-17 US US10/245,133 patent/US6844466B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005505571A (ja) | 2005-02-24 |
| BR0212583A (pt) | 2004-10-13 |
| CA2460693C (en) | 2010-12-07 |
| CN1555359A (zh) | 2004-12-15 |
| AR036533A1 (es) | 2004-09-15 |
| KR100896550B1 (ko) | 2009-05-07 |
| JP4421293B2 (ja) | 2010-02-24 |
| CA2460693A1 (en) | 2003-03-27 |
| KR20040035809A (ko) | 2004-04-29 |
| US6844466B2 (en) | 2005-01-18 |
| AU2002329276B2 (en) | 2008-04-24 |
| MXPA04002590A (es) | 2004-06-18 |
| US20030158226A1 (en) | 2003-08-21 |
| EP1430024A1 (en) | 2004-06-23 |
| CN1283621C (zh) | 2006-11-08 |
| RU2004111787A (ru) | 2005-10-20 |
| WO2003024921A1 (en) | 2003-03-27 |
| RU2299877C2 (ru) | 2007-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL369108A1 (en) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| CA2449729A1 (en) | Prodrugs of gaba analogs, compositions and uses thereof | |
| AU2003256755A1 (en) | Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations | |
| MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
| JO2434B1 (en) | New retinoids to treat emphysema | |
| MXPA04002070A (es) | Compuestos de indazol sustituidos para el tratamiento de la inflamacion. | |
| IL162214A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
| WO2001081310A8 (en) | 1-aroyl-piperidinyl benzamidines | |
| WO2004043341A3 (en) | Treatment for hemorrhagic shock | |
| MEP54608A (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| GB0002336D0 (en) | Medicaments | |
| DE60205899D1 (en) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| PL370361A1 (en) | Alkyl urea retinoid agonists i | |
| TW200505443A (en) | Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases | |
| AU4179399A (en) | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders | |
| WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
| PL370459A1 (en) | Substituted urea retinoid agonists ii | |
| GB9907571D0 (en) | Compounds | |
| BR0008603A (pt) | Método para tratamento de copd | |
| IL168308A (en) | Compositions containing roflumilast and formoterol | |
| WO2002096870A3 (en) | Sponge-derived terpenoids and methods of use | |
| WO2003094967A3 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VOID | Decisions declaring the decisions on the grant of the patent lapsed |